tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate

C109H130BrCoN58O42S8- — CID 172929675

IUPACtetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate
SMILESCCC1(C)C(/C=C/c2ccc(N(C)C)cc2OC)=[N+](C)c2ccc(Br)cc21.N/C=N\N.N/C=N\N.N/C=N\N.N/C=N\N.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.O.O.O.O.O.O.O.O=C1C=CC(=NN=c2[n-]cc([N+](=O)[O-])s2)C(O)=C1.O=C1C=CC(=NN=c2[n-]cc([N+](=O)[O-])s2)C(O)=C1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.[Co].[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O
InChIInChI=1S/C23H28BrN2O.5C9H6N4O4S.4C7H7N3O2.3C3H4N4O2S.4CH5N3.Co.7H2O/c1-7-23(2)19-14-17(24)10-12-20(19)26(5)22(23)13-9-16-8-11-18(25(3)4)15-21(16)27-6;5*14-5-1-2-6(7(15)3-5)11-12-9-10-4-8(18-9)13(16)17;4*8-4-9-10-6-2-1-5(11)3-7(6)12;3*4-6-3-5-1-2(10-3)7(8)9;4*2-1-4-3;;;;;;;;/h8-15H,7H2,1-6H3;2*1-4H,(H2,10,12,14,15);3*1-4,14-15H;4*1-4,8,11-12H;3*1H,4H2,(H,5,6);4*1H,3H2,(H2,2,4);;7*1H2/q+1;;;;;;;;;;;;;;;;;;;;;;;;/p-2/b;;;3*12-11+;4*8-4+,10-9+;;;;;;;;;;;;;;;
InChIKeyYQMGIQLCLCNKDI-INVNTUAGSA-L
MW3319.98 g/mol
LogP12.95
Rot. Bonds32

About tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate

tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate (PubChem CID 172929675) has the molecular formula C109H130BrCoN58O42S8- and a molecular weight of 3319.98 g/mol. Its IUPAC name is tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate.

Molecular Properties

Compound Nametetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate
PubChem CID172929675
Molecular FormulaC109H130BrCoN58O42S8-
Molecular Weight3319.98 g/mol
Exact Mass3316.61
IUPAC Nametetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate
SMILESCCC1(C)C(/C=C/c2ccc(N(C)C)cc2OC)=[N+](C)c2ccc(Br)cc21.N/C=N\N.N/C=N\N.N/C=N\N.N/C=N\N.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.O.O.O.O.O.O.O.O=C1C=CC(=NN=c2[n-]cc([N+](=O)[O-])s2)C(O)=C1.O=C1C=CC(=NN=c2[n-]cc([N+](=O)[O-])s2)C(O)=C1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.[Co].[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O
InChIInChI=1S/C23H28BrN2O.5C9H6N4O4S.4C7H7N3O2.3C3H4N4O2S.4CH5N3.Co.7H2O/c1-7-23(2)19-14-17(24)10-12-20(19)26(5)22(23)13-9-16-8-11-18(25(3)4)15-21(16)27-6;5*14-5-1-2-6(7(15)3-5)11-12-9-10-4-8(18-9)13(16)17;4*8-4-9-10-6-2-1-5(11)3-7(6)12;3*4-6-3-5-1-2(10-3)7(8)9;4*2-1-4-3;;;;;;;;/h8-15H,7H2,1-6H3;2*1-4H,(H2,10,12,14,15);3*1-4,14-15H;4*1-4,8,11-12H;3*1H,4H2,(H,5,6);4*1H,3H2,(H2,2,4);;7*1H2/q+1;;;;;;;;;;;;;;;;;;;;;;;;/p-2/b;;;3*12-11+;4*8-4+,10-9+;;;;;;;;;;;;;;;
InChIKeyYQMGIQLCLCNKDI-INVNTUAGSA-L
XLogP12.95
TPSA1734.09 Ų
H-Bond Donors34
H-Bond Acceptors82
Rotatable Bonds32
Heavy Atoms219
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003319.98
LogP ≤ 512.95
H-Bond Donors ≤ 534
H-Bond Acceptors ≤ 1082

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quinone_A(370)', 'substructure': 'N/A'}, {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'anil_di_alk_B(251)', 'substructure': 'N/A'}, {'alert_name': 'chinone_1', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}

Analyze tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate?
The IUPAC name of tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate (CID 172929675) is tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate.
What is the SMILES notation for tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate?
The canonical SMILES for tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate is CCC1(C)C(/C=C/c2ccc(N(C)C)cc2OC)=[N+](C)c2ccc(Br)cc21.N/C=N\N.N/C=N\N.N/C=N\N.N/C=N\N.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.O.O.O.O.O.O.O.O=C1C=CC(=NN=c2[n-]cc([N+](=O)[O-])s2)C(O)=C1.O=C1C=CC(=NN=c2[n-]cc([N+](=O)[O-])s2)C(O)=C1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.[Co].[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.
What is the InChIKey of tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate?
The InChIKey is YQMGIQLCLCNKDI-INVNTUAGSA-L. The full InChI is InChI=1S/C23H28BrN2O.5C9H6N4O4S.4C7H7N3O2.3C3H4N4O2S.4CH5N3.Co.7H2O/c1-7-23(2)19-14-17(24)10-12-20(19)26(5)22(23)13-9-16-8-11-18(25(3)4)15-21(16)27-6;5*14-5-1-2-6(7(15)3-5)11-12-9-10-4-8(18-9)13(16)17;4*8-4-9-10-6-2-1-5(11)3-7(6)12;3*4-6-3-5-1-2(10-3)7(8)9;4*2-1-4-3;;;;;;;;/h8-15H,7H2,1-6H3;2*1-4H,(H2,10,12,14,15);3*1-4,14-15H;4*1-4,8,11-12H;3*1H,4H2,(H,5,6);4*1H,3H2,(H2,2,4);;7*1H2/q+1;;;;;;;;;;;;;;;;;;;;;;;;/p-2/b;;;3*12-11+;4*8-4+,10-9+;;;;;;;;;;;;;;;.
What are the key properties of tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate?
tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate has a molecular weight of 3319.98 g/mol, XLogP of 12.95, 32 rotatable bonds, 34 hydrogen bond donors, and 82 hydrogen bond acceptors.
Where does this data come from?
All data for tetrakis(N'-aminomethanimidamide);4-[(E)-2-(5-bromo-3-ethyl-1,3-dimethylindol-1-ium-2-yl)ethenyl]-3-methoxy-N,N-dimethylaniline;cobalt;tetrakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);tris(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);tris((5-nitro-1,3-thiazol-2-yl)hydrazine);heptahydrate is sourced from PubChem (CID 172929675), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).